Latest Breaking News On - Roch perjeta - Page 1 : comparemela.com

/PRNewswire/ EirGenix, Inc. (6589.TT) announced on 28th of April that it has completed the phase 1 clinical trial (EGC101) of its second breast cancer.

Xinzhu xianT ai peiRoch perjetaTaiwan national health insuranceEirgenix incSwiss francsNew taiwan dollarsNational health insuranceZhubei commercial production